Literature DB >> 8794704

Horizontal transposition of the vertical rectus muscles for cyclotropia.

G K von Noorden1, R H Jenkins, M W Chu.   

Abstract

PURPOSE: We studied the effect of horizontal transposition of the vertical rectus muscles on incyclotropia and excyclotropia in terms of the amount of correction obtained and the stability of the outcome.
METHOD: Preoperative measurements for cyclotropia were compared in 11 patients with measurements during the immediate postoperative period and last follow-up. Excyclotropia was treated with nasal transposition of the inferior rectus muscle and incyclotropia with nasal transposition of the superior rectus muscle, to which we added temporal transposition to the inferior rectus muscle in one patient to enhance the effect.
RESULTS: Fusion in all gaze positions was restored in six patients and functional improvement occurred in five. The average effect of horizontal transposition of one vertical rectus muscle for cyclotropia was a correction of 7 degrees in primary position and of 11 degrees in depression. This effect remained stable after a mean follow-up of 17 months, and additional improvement occurred in one patient. One patient developed a hypertropia, eliminated by an additional operation, in the treated eye.
CONCLUSIONS: For excyclotropia, nasal transposition of the inferior rectus muscle is a viable alternative to lateral and anterior transposition of the anterior portion of the superior oblique tendon. It becomes the procedure of choice when surgery on the superior oblique tendon is precluded, either by the tendon's congenital absence or by previous surgery on the tendon. Nasal transposition of the superior rectus muscle or temporal transposition of the inferior rectus muscle is ideally suited for incyclotropia. No comparably effective operation exists.

Entities:  

Mesh:

Year:  1996        PMID: 8794704     DOI: 10.1016/s0002-9394(14)72058-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Effects of vertical muscle surgery on differences in the orientation of Listing's plane in patients with superior oblique palsy.

Authors:  Manabu Miyata; Yoshie Shira; Reika Kono; Ichiro Hamasaki; Satoshi Hasebe; Hiroshi Ohtsuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-25       Impact factor: 3.117

2.  Adjustable small-incision selective tenotomy and plication for correction of incomitant vertical strabismus and torsion.

Authors:  Melinda Y Chang; Stacy L Pineles; Federico G Velez
Journal:  J AAPOS       Date:  2015-10       Impact factor: 1.220

3.  Anterior segment ischemia: etiology, assessment, and management.

Authors:  S L Pineles; M Y Chang; E L Oltra; M S Pihlblad; J P Davila-Gonzalez; T C Sauer; F G Velez
Journal:  Eye (Lond)       Date:  2017-11-17       Impact factor: 3.775

4.  Clinical factors underlying a single surgery or repetitive surgeries to treat superior oblique muscle palsy.

Authors:  Kana Aoba; Toshihiko Matsuo; Ichiro Hamasaki; Kayoko Hasebe
Journal:  Springerplus       Date:  2015-04-07

5.  Surgical effects of nasal transposition of inferior rectus muscle - 135 cases of acquired superior oblique palsy.

Authors:  Mana Okamoto; Akiko Kimura; Akiko Masuda; Osamu Mimura
Journal:  Clin Ophthalmol       Date:  2015-04-18

6.  Two cases of acquired bilateral trochlea nerve palsy treated by simultaneous inferior rectus muscle nasal transposition and inferior oblique muscle myectomy.

Authors:  Miwa Komori; Hiroko Suzuki; Hirohito Iimori; Akiko Hikoya; Yoshihiro Hotta; Miho Sato
Journal:  Am J Ophthalmol Case Rep       Date:  2021-01-12

7.  Inferior rectus nasal transposition as a procedure of choice for acquired superior oblique palsy.

Authors:  Hrishikesh Kaza; Vivekanand U Warkad
Journal:  Clin Ophthalmol       Date:  2015-11-09

8.  Reliability and reproducibility of disc-foveal angle measurements by non-mydriatic fundus photography.

Authors:  Caroline Le Jeune; Fayçal Chebli; Lorette Leon; Emmanuelle Anthoine; Michel Weber; Alain Péchereau; Pierre Lebranchu
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.